1. Home
  2. OCX vs PMAX Comparison

OCX vs PMAX Comparison

Compare OCX & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCX
  • PMAX
  • Stock Information
  • Founded
  • OCX 2009
  • PMAX 2019
  • Country
  • OCX United States
  • PMAX Hong Kong
  • Employees
  • OCX N/A
  • PMAX N/A
  • Industry
  • OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PMAX
  • Sector
  • OCX Health Care
  • PMAX
  • Exchange
  • OCX Nasdaq
  • PMAX Nasdaq
  • Market Cap
  • OCX 35.1M
  • PMAX 32.0M
  • IPO Year
  • OCX N/A
  • PMAX 2024
  • Fundamental
  • Price
  • OCX $2.01
  • PMAX $0.44
  • Analyst Decision
  • OCX Buy
  • PMAX
  • Analyst Count
  • OCX 3
  • PMAX 0
  • Target Price
  • OCX $4.42
  • PMAX N/A
  • AVG Volume (30 Days)
  • OCX 53.0K
  • PMAX 4.2M
  • Earning Date
  • OCX 11-12-2024
  • PMAX 02-14-2025
  • Dividend Yield
  • OCX N/A
  • PMAX N/A
  • EPS Growth
  • OCX N/A
  • PMAX N/A
  • EPS
  • OCX N/A
  • PMAX 0.04
  • Revenue
  • OCX $709,000.00
  • PMAX $5,970,263.00
  • Revenue This Year
  • OCX N/A
  • PMAX N/A
  • Revenue Next Year
  • OCX $106.34
  • PMAX N/A
  • P/E Ratio
  • OCX N/A
  • PMAX $10.26
  • Revenue Growth
  • OCX N/A
  • PMAX 30.05
  • 52 Week Low
  • OCX $1.92
  • PMAX $0.34
  • 52 Week High
  • OCX $3.48
  • PMAX $4.70
  • Technical
  • Relative Strength Index (RSI)
  • OCX 42.58
  • PMAX N/A
  • Support Level
  • OCX $1.99
  • PMAX N/A
  • Resistance Level
  • OCX $2.30
  • PMAX N/A
  • Average True Range (ATR)
  • OCX 0.12
  • PMAX 0.00
  • MACD
  • OCX 0.02
  • PMAX 0.00
  • Stochastic Oscillator
  • OCX 25.70
  • PMAX 0.00

About OCX Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

Share on Social Networks: